These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 8998787

  • 1. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P, Chiariello M.
    Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G, Marsico F, Micheletti T, Bona M.
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract] [Full Text] [Related]

  • 4. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A, Bergamaschi M, Gromo G, Nonaka K, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Dec; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [K-channel activators and cardioprotection].
    Specchia G, Marsico F, Laudisa ML.
    Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
    [Abstract] [Full Text] [Related]

  • 8. [Potassium agonists].
    Hellwig B.
    Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166
    [No Abstract] [Full Text] [Related]

  • 9. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.
    Zhang S, Sakai K, Hasuo H, Furuta K, Ureshino H, Shibata O, Sumikawa K.
    Res Commun Mol Pathol Pharmacol; 1999 Jun; 105(1-2):115-27. PubMed ID: 10850375
    [Abstract] [Full Text] [Related]

  • 10. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H.
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ.
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of bolus nicorandil compared with nitroglycerin.
    Utoh J, Miyauchi Y, Goto H, Obayashi H, Hirata T.
    Am J Emerg Med; 1995 Sep; 13(5):610-2. PubMed ID: 7662070
    [No Abstract] [Full Text] [Related]

  • 16. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
    Pérez-Vizcaíno F, Cogolludo AL, Villamor E, Tamargo J.
    Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.